David Henry Mack - Aug 13, 2024 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
President and CEO, Director
Signature
/s/ Robert Ticktin, by power of attorney
Stock symbol
PMVP
Transactions as of
Aug 13, 2024
Transactions value $
$0
Form type
4
Date filed
10/3/2024, 04:44 PM
Previous filing
Jan 22, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Employee Stock Option (right to buy) Disposed to Issuer -135K -100% 0 Aug 13, 2024 Common Stock 135K $28.33 Direct F1, F2
transaction PMVP Employee Stock Option (right to buy) Disposed to Issuer -250K -100% 0 Aug 13, 2024 Common Stock 250K $16.29 Direct F3, F4
transaction PMVP Employee Stock Option (right to buy) Award +384K 384K Aug 13, 2024 Common Stock 384K $1.48 Direct F2, F4, F5
transaction PMVP Employee Stock Option (right to buy) Disposed to Issuer -330K -100% 0 Aug 13, 2024 Common Stock 330K $5.70 Direct F6, F7
transaction PMVP Employee Stock Option (right to buy) Award +330K 330K Aug 13, 2024 Common Stock 330K $1.48 Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2021.
F2 On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 134,584 shares of PMV common stock granted to the reporting person on May 12, 2021. In exchange, the reporting person received a replacement option, for 134,584 shares, having an exercise price of $1.48 per share.
F3 Shares subject to the option vest in 48 equal monthly installments beginning on March 10, 2022.
F4 On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 249,600 shares of PMV common stock granted to the reporting person on February 10, 2022. In exchange, the reporting person received a replacement option, for 249,600 shares, having an exercise price of $1.48 per share.
F5 One-third of the shares subject to the option vest on August 13, 2025 and 1/36th vest monthly thereafter.
F6 Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2023.
F7 On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 330,000 shares of PMV common stock granted to the reporting person on May 12, 2023. In exchange, the reporting person received a replacement option, for 330,000 shares, having an exercise price of $1.48 per share.
F8 One-fourth of the shares subject to the option vest on August 13, 2025 and 1/48th vest monthly thereafter.